Abstracts tagged "Pulmonary Involvement and vasculitis"

Abstract Number: 1760 • 2017 ACR/ARHP Annual Meeting
Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis
Saara M. Rawn¹, Gerard Cox¹, Christian Pagnoux², David Cuthbertson³, Simon Carette², Curry L. Koening⁴, Carol A. Langford⁵, Carol A. McAlear⁶, Paul A. Monach⁷, Larry W. Moreland⁸, Philip Seo⁹, Ulrich Specks¹⁰, Antoine G. Sreih¹¹, Steven R. Ytterberg¹², Renee Borchin¹³, Peter A. Merkel¹¹ and Nader A. Khalidi¹, ¹St. Joseph's Healthcare, McMaster University, Hamilton, ON, Canada, ²Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ³Department of Biostatistics, University of South Florida, Tampa, FL, ⁴Rheumatology, University of Utah, Salt Lake City, UT, ⁵Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ⁶Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁷Rheumatology, Boston University, Boston, MA, ⁸Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁹Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ¹⁰Mayo Clinic, Rochester, MN, ¹¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹²Division of Rheumatology, Mayo Clinic, Rochester, MN, ¹³University of South Florida, Tampa, FL
Background/Purpose: Pulmonary involvement in microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) includes pulmonary nodules (PN), diffuse alveolar hemorrhage (DAH), and infiltrates attributed to vasculitis,…
Abstract Number: 3051 • 2015 ACR/ARHP Annual Meeting
Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behçet’s Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment
Vedat Hamuryudan¹, Emire Seyahi², Serdal Ugurlu³, Fatih Gulsen⁴, Canan Akman⁴, Murat Cantasdemir⁴, Furuzan Numan⁴, Hasan Tuzun⁵ and Hasan Yazici⁶, ¹Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ²Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Turkey, Istanbul, Turkey, ³Rheumatology, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ⁴Cerrahpasa Medical Faculty, University of Istanbul, Department of Radiology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ⁵Cerrahpasa Medical Faculty, University of Istanbul, Department of Vascular Surgery, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ⁶Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
Background/Purpose: Hemoptysis is the most frequent and feared symptom of pulmonary artery involvement (PAI) in Behçet’s syndrome (BS). Some BS patients with PAI experience recurrent…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].